首页> 美国卫生研究院文献>Frontiers in Physiology >The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
【2h】

The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease

机译:CXCL12 / CXCR4趋化因子配体/受体轴在心血管疾病中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The chemokine receptor CXCR4 and its ligand CXCL12 play an important homeostatic function by mediating the homing of progenitor cells in the bone marrow and regulating their mobilization into peripheral tissues upon injury or stress. Although the CXCL12/CXCR4 interaction has long been regarded as a monogamous relation, the identification of the pro-inflammatory chemokine macrophage migration inhibitory factor (MIF) as an important second ligand for CXCR4, and of CXCR7 as an alternative receptor for CXCL12, has undermined this interpretation and has considerably complicated the understanding of CXCL12/CXCR4 signaling and associated biological functions. This review aims to provide insight into the current concept of the CXCL12/CXCR4 axis in myocardial infarction (MI) and its underlying pathologies such as atherosclerosis and injury-induced vascular restenosis. It will discuss main findings from in vitro studies, animal experiments and large-scale genome-wide association studies. The importance of the CXCL12/CXCR4 axis in progenitor cell homing and mobilization will be addressed, as will be the function of CXCR4 in different cell types involved in atherosclerosis. Finally, a potential translation of current knowledge on CXCR4 into future therapeutical application will be discussed.
机译:趋化因子受体CXCR4及其配体CXCL12通过介导骨髓中祖细胞的归巢并在受伤或应激时调节其向周围组织的动员,发挥着重要的稳态功能。尽管长期以来一直将CXCL12 / CXCR4相互作用视为一夫一妻制的关系,但对促炎性趋化因子巨噬细胞迁移抑制因子(MIF)作为CXCR4的重要第二配体以及作为CXCL12的替代受体的CXCR7的鉴定已被破坏。这种解释使CXCL12 / CXCR4信号传导和相关生物学功能的理解大大复杂化。这篇综述旨在提供对心肌梗死(MI)中CXCL12 / CXCR4轴的当前概念及其潜在病理学(如动脉粥样硬化和损伤引起的血管再狭窄)的见解。它将讨论体外研究,动物实验和大规模全基因组关联研究的主要发现。将解决CXCL12 / CXCR4轴在祖细胞归巢和动员中的重要性,以及CXCR4在涉及动脉粥样硬化的不同细胞类型中的功能。最后,将讨论有关CXCR4的当前知识到未来治疗应用的潜在翻译。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号